← Back to headlines
Merck's Keytruda Shows Survival Benefit in Ovarian Cancer
Merck's cancer drug Keytruda has demonstrated an overall survival benefit in patients with ovarian cancer, according to new findings.
27 Feb, 16:38 — 27 Feb, 16:38
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
Kwara unveils safer birth training to curb maternal, child deaths
just now
NAFDAC restates ban on multi-dose anti-malaria suspension
5m ago
Finnish Law Clarification on Female Genital Mutilation and Community Prevention Efforts
13m ago
Scabies Outbreak Among Foreign Workers at Stellantis in Kragujevac, Serbia
27m ago